Clinical trials
Skin clinical trials
Below are recruiting skin clinical trials, each written for real people, not researchers. We’re tracking 645 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07359430Recruiting
Deep phenotyping of chronic inducible urticaria
This study aims to better understand inducible urticaria (hives triggered by cold, pressure, or friction) and chronic spontaneous urticaria. Researchers will use skin tests to measure how different triggers affect your skin in detail.
Leiden, South HollandAges 18 years+ - NCT07354152Recruiting
Flap vs skin graft for melanoma wound closure
This study compares two ways of closing a large wound after melanoma removal: using a skin flap (where nearby tissue is moved to cover the defect) versus a skin graft (taking a thin layer of skin from another area). It aims to see which method works better for healing.
Nantes, NantesAges 18 years+ - NCT05287646Recruiting
Track how your residual limb moves while walking with a prosthesis
This study uses a special X-ray and markers to measure how your leg and skin move inside your prosthetic socket while you walk. It may help researchers better understand fit and comfort for people with transtibial (below-knee) amputations.
New York, New YorkAges 18 years+ - NCT07545720RecruitingPhase 2
Pinoxin to prevent radiation skin damage
This study tests whether a protective agent called Pinoxin can prevent or reduce skin damage from radiation therapy. If you're getting radiation treatment for cancer, this trial may help protect your skin during therapy.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07349303RecruitingPhase 2
Pembrolizumab Before Surgery for Stage IIb/c Melanoma
This trial tests whether giving pembrolizumab (Keytruda) before surgery helps people with a certain type of advanced melanoma (stage IIb/c). The goal is to see if this treatment can improve outcomes before the tumor is removed.
GothenburgAges 18 years+ - NCT07345052Recruiting
Study on systemic sclerosis in western Sweden
This study is looking at people with systemic sclerosis (a condition that causes hardening and tightening of the skin and can affect internal organs) to learn more about the disease. You may join if you have been diagnosed with this condition and meet a few other requirements.
Gothenburg, SwedenAges 18 years+ - NCT07341737RecruitingPhase 1/Phase 2
SL-28 for advanced solid tumors that haven’t responded to treatment
This trial tests a new drug, SL-28, for people with advanced solid tumors that haven’t responded to or cannot be treated with standard therapies. It aims to find a safe dose and see if the drug can help shrink or slow the growth of your cancer.
Sydney, New South WalesAges 18 years+ - NCT07339176RecruitingPhase 1/Phase 2
A trial of N17350 injected into tumors for advanced solid cancers
This trial tests an experimental drug, N17350, that is injected directly into tumors. It is for people with advanced solid tumors that have stopped responding to standard treatments or who cannot receive them. The study aims to see if this approach is safe and effective.
Los Angeles, CaliforniaAges 18 years+ - NCT07341906Enrolling by invitation
AI vs. dermatologist for skin diagnosis
This study tests whether an AI tool can help general practitioners diagnose skin conditions as accurately as a dermatologist. If you are an adult whose doctor already used OMNIDOC to send a skin image for expert review, you may be able to take part.
Nice, Alpes MaritimesAges 18 years+ - NCT07338695Enrolling by invitation
Light therapy’s effect on blood flow in healthy adults
This study tests if shining a specific type of light on your skin can improve blood flow in tiny blood vessels. You'll come in for two sessions where we apply different light wavelengths and measure your skin’s response.
Tel AvivAges 20–75 - NCT06791525RecruitingPhase 4
Testing a new wart cream for kids ages 8 to 18
This study is testing an ointment called tirbanibulin to treat warts on the hands of children and teens. It may offer a new option if other treatments haven't worked.
New City, New YorkAges 8–18 - NCT07329114Recruiting
Testing an electrical dressing for infected wounds
This trial tests a special 'electroceutical' dressing that uses low-level electrical signals to help heal infected traumatic wounds. It may help people with wounds that are not healing well and show signs of infection.
Ivano-FrankivskAges 18–105 - NCT05401292RecruitingPhase 4
Skin prep for planned foot and ankle surgery
This trial studies whether a specific skin-prep approach before elective (planned) foot and ankle surgery can help prevent infection. You may be able to take part if your surgery is not for an injury and you meet the age and health requirements.
Columbia, MissouriAges 18 years+ - NCT07319273Recruiting
Child Life Services for Kids' Allergy Skin Tests
This study is testing whether a special program called 'Child Life Services' can help children feel more comfortable and less anxious during a skin prick test, which is a common allergy test. The goal is to make the experience easier for kids and their families.
ShanghaiAges 1–18 - NCT07320664Recruiting
Alcohol and Breast Cancer Risk in Young Women
This study looks at how drinking alcohol affects young women's understanding of breast cancer risk. It involves answering questions and possibly wearing a sensor to track drinking.
Columbus, OhioAges 18–25 - NCT07322146Enrolling by invitationPhase 4
Shorter antibiotics for children with common infections
This study tests whether shorter courses of antibiotics are as effective as longer ones for children hospitalized with pneumonia, skin infections, or urinary tract infections. It may help children get back to normal faster and reduce side effects.
Birmingham, AlabamaAges 2 months–17 years - NCT07312383Recruiting
Skin blood flow study in leg artery disease
This trial uses a special device to measure tiny blood vessels in the skin of patients with severe leg artery disease. It aims to understand how blood flow changes before and after a common treatment to open blocked leg arteries (angioplasty).
OsloAges 18 years+ - NCT07311070Enrolling by invitationPhase 3
Methylene blue gel for skin cancer not treated by surgery or radiation
This trial tests a methylene blue gel for people with certain types of basal cell carcinoma (a common skin cancer) who cannot have surgery or radiation. The goal is to see if the gel can treat the cancer safely and effectively.
Mashhad, Razavi Khorasan ProvinceAges 18 years+ - NCT07292415Recruiting
Nerve repair using Matriderm for finger nerve injuries
This trial tests a special material called Matriderm to help repair damaged nerves in fingers or palms after an injury. It compares Matriderm to standard nerve repair to see if it leads to better recovery.
Nice, Alpes MaritimesAges 16–75 - NCT07296588Enrolling by invitation
Expert opinions on sun protection practices
This study asks experts in skin protection to share their opinions through a few rounds of surveys. The goal is to reach agreement on the best ways to protect skin from the sun.
CairoAges 25 years+ - NCT07288827Recruiting
Study of airway sensitivity in primary ciliary dyskinesia
This study looks at how the airways in people with primary ciliary dyskinesia (PCD) react to certain triggers. It aims to understand if these airways are more sensitive, which could help improve treatment for breathing problems.
Indianapolis, IndianaAges 6 years+ - NCT07288073RecruitingPhase 2
TIL Therapy for Advanced Skin Cancer Patients
This study tests a personalized cell therapy called TIL (tumor-infiltrating lymphocytes) for people with advanced skin cancers that have not responded to immunotherapy. Doctors take your tumor cells, grow immune cells from them, and then infuse them back to fight the cancer.
Boston, MassachusettsAges 18 years+ - NCT07287917RecruitingPhase 1/Phase 2
Testing a new drug combo for advanced breast cancer or melanoma
This trial tests a new combination of drugs (AMXT 1501, DFMO, and standard therapies) for people with advanced solid tumors, specifically breast cancer (ER+ HER2-) or melanoma that has progressed after other treatments. The goal is to see if this combination can help shrink tumors or slow their growth.
Tucson, ArizonaAges 18 years+ - NCT07286123Recruiting
Vaginoplasty using fish skin graft for transgender women
This trial tests a new surgical technique for gender-affirming vaginoplasty that uses a fish skin graft (Kerecis) to create the vaginal lining. It may be an option for transgender women planning this type of surgery for the first time.
Cleveland, OhioAges 19–99
Hear when a new Skin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for skin?
- Yes. Clin2 currently lists 645 recruiting skin studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a skin trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a skin trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.